Correlation Between Seres Therapeutics and PDS Biotechnology
Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and PDS Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and PDS Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seres Therapeutics and PDS Biotechnology Corp, you can compare the effects of market volatilities on Seres Therapeutics and PDS Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of PDS Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and PDS Biotechnology.
Diversification Opportunities for Seres Therapeutics and PDS Biotechnology
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Seres and PDS is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and PDS Biotechnology Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PDS Biotechnology Corp and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with PDS Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PDS Biotechnology Corp has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and PDS Biotechnology go up and down completely randomly.
Pair Corralation between Seres Therapeutics and PDS Biotechnology
Given the investment horizon of 90 days Seres Therapeutics is expected to generate 1.37 times more return on investment than PDS Biotechnology. However, Seres Therapeutics is 1.37 times more volatile than PDS Biotechnology Corp. It trades about 0.09 of its potential returns per unit of risk. PDS Biotechnology Corp is currently generating about -0.35 per unit of risk. If you would invest 70.00 in Seres Therapeutics on August 27, 2024 and sell it today you would earn a total of 7.00 from holding Seres Therapeutics or generate 10.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Seres Therapeutics vs. PDS Biotechnology Corp
Performance |
| Timeline |
| Seres Therapeutics |
| PDS Biotechnology Corp |
Seres Therapeutics and PDS Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Seres Therapeutics and PDS Biotechnology
The main advantage of trading using opposite Seres Therapeutics and PDS Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, PDS Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PDS Biotechnology will offset losses from the drop in PDS Biotechnology's long position.| Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
| PDS Biotechnology vs. Mereo BioPharma Group | PDS Biotechnology vs. Terns Pharmaceuticals | PDS Biotechnology vs. Inozyme Pharma | PDS Biotechnology vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |